Home » Topics » Regulatory » EMA

EMA
RSS

EMA recommends approval of Nuwiq for children and adults with hemophilia A

May 27, 2014

EMA committee hands down positive opinion on Arzerra for CLL

May 27, 2014

EMA's CHMP recommends approval of Simbrinza to reduce IOP

May 27, 2014

EMA committee makes Halaven recommendation

May 27, 2014

CHMP adopts positive opinion for Plegridy as a treatment for multiple sclerosis

May 27, 2014

EMA committee recommends approval of obinutuzumab

May 26, 2014

CHMP issues positive opinion for Translarna for nonsense mutation DMD

May 26, 2014

TxCell's Col-Treg receives Advanced Therapy Medicinal Product designation

May 26, 2014

CHMP issues positive opinion for Envarsus in kidney and liver transplant patients

May 23, 2014

MOR-208 receives FDA and EMA orphan drug designations

May 21, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...